Cargando…

Human papillomavirus infection in head and neck cancer: The role of the secretory leukocyte protease inhibitor

We previously showed that secretory leukocyte protease inhibitor (SLPI) gene and protein expression is significantly lower in metastatic versus non-metastatic head and neck squamous cell carcinoma (HNSCC). However, we did not assess the human papillomavirus (HPV) status of these cases. Since SLPI pl...

Descripción completa

Detalles Bibliográficos
Autores principales:	HOFFMANN, MARKUS, QUABIUS, ELGAR S., TRIBIUS, SILKE, HEBEBRAND, LENA, GÖRÖGH, TIBOR, HALEC, GORDANA, KAHN, TOMAS, HEDDERICH, JÜRGEN, RÖCKEN, CHRISTOPH, HAAG, JOCHEN, WATERBOER, TIM, SCHMITT, MARKUS, GIULIANO, ANNA R., KAST, W. MARTIN
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2013
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658815/ https://www.ncbi.nlm.nih.gov/pubmed/23467841 http://dx.doi.org/10.3892/or.2013.2327

Ejemplares similares

miRNA-expression in tonsillar squamous cell carcinomas in relation to HPV infection and expression of the antileukoproteinase SLPI
por: Quabius, Elgar Susanne, et al.
Publicado: (2017)

Head and neck cancer cells and xenografts are very sensitive to palytoxin: decrease of c-jun n-terminale kinase-3 expression enhances palytoxin toxicity
por: Görögh, Tibor, et al.
Publicado: (2013)

Sequential activation of the AKT pathway in human osteoblasts treated with Oscarvit: a bioactive product with positive effect both on skeletal pain and mineralization in osteoblasts
por: Görögh, Tibor, et al.
Publicado: (2017)

Relevance of Human Papillomaviruses in Head and Neck Cancer—What Remains in 2021 from a Clinician’s Point of View?
por: Hoffmann, Markus, et al.
Publicado: (2021)

Sensitivity and Specificity of Human Papillomavirus (HPV) 16 Early Antigen Serology for HPV-Driven Oropharyngeal Cancer: A Systematic Literature Review and Meta-Analysis
por: Hibbert, Julia, et al.
Publicado: (2021)

HPV DNA/RNA detection in various oral and oropharyngeal biomaterials identifies active HPV infections also in non-neoplastic tonsils
por: Quabius, Elgar Susanne, et al.
Publicado: (2020)

Oral secretory leukocyte protease inhibitor (SLPI): Associations with oropharyngeal cancer and treatment outcome
por: Dickey, Brittney L., et al.
Publicado: (2021)

Immunoregulatory role of secretory leukocyte protease inhibitor in allergic asthma
por: Marino, Rafael, et al.
Publicado: (2010)

Smoking-Induced SLPI Expression Hinders HPV Infections Also in Squamous Cell Carcinomas of the Vulva
por: Quabius, Elgar S., et al.
Publicado: (2018)

Effect of Semen on Vaginal Fluid Cytokines and Secretory Leukocyte Protease Inhibitor
por: Agnew, Kathy J., et al.
Publicado: (2008)

HPV and Oropharyngeal Cancer in the Eighth Edition of the TNM Classification: Pitfalls in Practice
por: Hoffmann, Markus, et al.
Publicado: (2019)

Secretory leukocyte protease inhibitor in punch biopsies from human colonic mucosa.
por: Nyström, M, et al.
Publicado: (2001)

Endogenous secretory leukocyte protease inhibitor inhibits microbial‐induced monocyte activation
por: Nugteren, Sandrine, et al.
Publicado: (2022)

Secretory Leukocyte Protease Inhibitor Is an Inducible Antimicrobial Peptide Expressed in Staphylococcus aureus Endophthalmitis
por: Reviglio, Victor E., et al.
Publicado: (2007)

The cardioprotective effects of secretory leukocyte protease inhibitor against myocardial ischemia/reperfusion injury
por: Prompunt, Eakkapote, et al.
Publicado: (2018)

Secretory leukocyte protease inhibitor and risk of heart failure in the Multi-Ethnic Study of Atherosclerosis
por: Sawicki, Konrad Teodor, et al.
Publicado: (2023)

Secretory Leukocyte Protease Inhibitor Protects Against Severe Urinary Tract Infection in Mice
por: Rosen, Anne L., et al.
Publicado: (2023)

Expression of secretory leukocyte protease inhibitor detected by immunohistochemistry correlating with prognosis and metastasis in colorectal cancer
por: Liu, Guiying, et al.
Publicado: (2014)

The Ability of Secretory Leukocyte Protease Inhibitor to Inhibit Apoptosis in Monocytes Is Independent of Its Antiprotease Activity
por: McGarry, Niamh, et al.
Publicado: (2015)

Upregulated Expression of Secretory Leukocyte Protease Inhibitor in Lung by Inhalation of High Concentration of Sulfur Dioxide
por: Liu, Lei, et al.
Publicado: (2018)

Secretory leukocyte protease inhibitor regulates nerve reflex‐mediated skin barrier function in psoriasis
por: Kwiecinska, P., et al.
Publicado: (2022)

Elevated Concentrations of SERPINE2/Protease Nexin-1 and Secretory Leukocyte Protease Inhibitor in the Serum of Patients with Papillary Thyroid Cancer
por: Stępień, Tomasz, et al.
Publicado: (2017)

Anti-Protease Activity Deficient Secretory Leukocyte Protease Inhibitor (SLPI) Exerts Cardioprotective Effect against Myocardial Ischaemia/Reperfusion
por: Mongkolpathumrat, Podsawee, et al.
Publicado: (2022)

Low prevalence of human papillomavirus in head and neck squamous cell carcinoma in the northwest region of the Philippines
por: Albano, Pia Marie, et al.
Publicado: (2017)

Secretory Leukocyte Protease Inhibitor Suppresses the Inflammation and Joint Damage of Bacterial Cell Wall–Induced Arthritis
por: Song, Xiao-yu, et al.
Publicado: (1999)

Secretory Leukocyte Protease Inhibitor Binds to Annexin II, a Cofactor for Macrophage HIV-1 Infection
por: Ma, Ge, et al.
Publicado: (2004)

Mucosal Progranulin expression is induced by H. pylori, but independent of Secretory Leukocyte Protease Inhibitor (SLPI) expression
por: Wex, Thomas, et al.
Publicado: (2011)

Effects of Pregnancy and Bacterial Vaginosis on Proinflammatory Cytokine and Secretory Leukocyte Protease Inhibitor Concentrations in Vaginal Secretions
por: Balkus, Jennifer, et al.
Publicado: (2010)

Increased Secretory Leukocyte Protease Inhibitor (SLPI) Production by Highly Metastatic Mouse Breast Cancer Cells
por: Sayers, Kevin T., et al.
Publicado: (2014)

Estimation and Comparison of Salivary Secretory Leukocyte Protease Inhibitor in Human Immunodeficiency Virus Patients and Healthy Individuals
por: Pushpanshu, Kumar, et al.
Publicado: (2014)

Secretory leukocyte protease inhibitor regulates human periodontal ligament cell production of pro-inflammatory cytokines
por: Svensson, Daniel, et al.
Publicado: (2017)

Secretory Leukocyte Protease Inhibitor Is Present in Circulating and Tissue-Recruited Human Eosinophils and Regulates Their Migratory Function
por: Osiecka, Oktawia, et al.
Publicado: (2022)

An in vitro endothelial cell protective effect of secretory leukocyte protease inhibitor against simulated ischaemia/reperfusion injury
por: Nernpermpisooth, Nitirut, et al.
Publicado: (2017)

Secretory leukocyte protease inhibitor (SLPI) as a potential target for inhibiting metastasis of triple-negative breast cancers
por: Kozin, Sergey V., et al.
Publicado: (2017)

Secretory leukocyte protease inhibitor gene deletion alters bleomycin-induced lung injury, but not development of pulmonary fibrosis
por: Habgood, Anthony N, et al.
Publicado: (2016)

Airway Microbiota-Host Interactions Regulate Secretory Leukocyte Protease Inhibitor Levels and Influence Allergic Airway Inflammation
por: Jaeger, Natalia, et al.
Publicado: (2020)

Airway Microbiota-Host Interactions Regulate Secretory Leukocyte Protease Inhibitor Levels and Influence Allergic Airway Inflammation
por: Jaeger, Natalia, et al.
Publicado: (2022)

Spatiotemporal expression and regulation of peptidase inhibitor 3 and secretory leukocyte protease inhibitor at the maternal–fetal interface in pigs
por: Lee, Soohyung, et al.
Publicado: (2023)

Human papillomavirus 16 is an aetiological factor of scrotal cancer
por: Guimerà, Núria, et al.
Publicado: (2017)

Secretory Leukocyte Protease Inhibitor (SLPI) Is, like Its Homologue Trappin-2 (Pre-Elafin), a Transglutaminase Substrate
por: Baranger, Kévin, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_g7c2hl3nd6svpurl2vgk85n4i8